FR2372806B1 - - Google Patents
Info
- Publication number
- FR2372806B1 FR2372806B1 FR7713518A FR7713518A FR2372806B1 FR 2372806 B1 FR2372806 B1 FR 2372806B1 FR 7713518 A FR7713518 A FR 7713518A FR 7713518 A FR7713518 A FR 7713518A FR 2372806 B1 FR2372806 B1 FR 2372806B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762619638 DE2619638A1 (de) | 1976-05-04 | 1976-05-04 | Pyrrolidone und verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2372806A1 FR2372806A1 (fr) | 1978-06-30 |
| FR2372806B1 true FR2372806B1 (fr) | 1980-02-29 |
Family
ID=5977020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7713518A Granted FR2372806A1 (fr) | 1976-05-04 | 1977-05-04 | Pyrrolidones, leur procede de preparation et leur application therapeutique |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS52133975A (fr) |
| BE (1) | BE854268A (fr) |
| DE (1) | DE2619638A1 (fr) |
| DK (1) | DK194377A (fr) |
| ES (1) | ES458264A1 (fr) |
| FR (1) | FR2372806A1 (fr) |
| GB (1) | GB1583163A (fr) |
| IT (1) | IT1086223B (fr) |
| NL (1) | NL7704739A (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4320136A (en) | 1980-08-11 | 1982-03-16 | E. I. Du Pont De Nemours And Company | 8-Aza-16,16-difluoroprostanoids |
| US4321201A (en) | 1980-09-22 | 1982-03-23 | E. I. Du Pont De Nemours And Company | Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates |
| US5021568A (en) * | 1988-04-22 | 1991-06-04 | Shipov Alexandr G | Lactam-1-acetic acid carbalkoxymethyl esters and method for preparing same |
| EE200200355A (et) | 1999-12-22 | 2003-10-15 | Pfizer Products Inc. | EP4 retseptori selektiivsed agonistid osteoporoosi raviks |
| WO2002024647A1 (fr) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine |
| MXPA03004623A (es) | 2000-11-27 | 2003-09-05 | Pfizer Prod Inc | Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis. |
| CA2451393C (fr) | 2001-07-16 | 2011-01-04 | F. Hoffmann-La Roche Ag | Derives de pyrrolidone comme antagonistes de prostanoide |
| EP1409455B1 (fr) | 2001-07-16 | 2006-01-04 | F. Hoffmann-La Roche Ag | Analogues de la prostaglandine utilises comme agonistes du recepteur ep4 |
| WO2003009872A1 (fr) * | 2001-07-23 | 2003-02-06 | Ono Pharmaceutical Co., Ltd. | Medicaments contenant un agoniste de ep4 en tant que principe actif destines aux maladies associees a une perte de la masse osseuse |
| BR0308166A (pt) | 2002-03-05 | 2005-01-18 | Ono Pharmaceutical Co | Compostos de derivados de 8-azaprostaglandina e drogas contendo os compostos como o ingrediente ativo |
| AU2003237520B2 (en) * | 2002-06-10 | 2009-01-08 | Laboratoires Serono Sa | Gamma lactams as prostaglandin agonists and use thereof |
| JP2006515015A (ja) | 2003-01-10 | 2006-05-18 | エフ．ホフマン−ラ ロシュ アーゲー | プロスタグランジンアゴニストとしての２−ピペリドン誘導体 |
| JP4582456B2 (ja) * | 2003-01-21 | 2010-11-17 | 小野薬品工業株式会社 | ８−アザプロスタグランジン誘導体およびその医薬用途 |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| US7858650B2 (en) | 2004-10-22 | 2010-12-28 | Ono Pharmaceutical Co., Ltd. | Medicinal composition for inhalation |
| CN106748951B (zh) | 2012-07-19 | 2020-07-24 | 开曼化学股份有限公司 | 作为在治疗ep4介导的疾病和病状中使用的ep4受体选择性激动剂的二氟内酰胺化合物 |
| WO2014144610A1 (fr) * | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Composés lactames en tant qu'agonistes sélectifs du récepteur ep4 pour l'utilisation dans le traitement de maladies et d'états à médiation par ep4 |
| JP6368351B2 (ja) | 2013-03-15 | 2018-08-01 | ケイマン ケミカル カンパニー， インコーポレーテッド | ジフルオロラクタムアナログを合成する方法 |
| EP3235817B1 (fr) | 2013-03-15 | 2018-12-12 | Cayman Chemical Company, Incorporated | Composés de lactamine en tant qu'agonistes sélectifs du récepteur ep4 destinés à être utilisés dans le traitement des maladies et affections transmises par l'ep4 |
| KR20160048054A (ko) | 2013-07-19 | 2016-05-03 | 카이맨 케미칼 컴파니 인코포레이티드 | 골 성장의 촉진을 위한 방법, 시스템 및 조성물 |
-
1976
- 1976-05-04 DE DE19762619638 patent/DE2619638A1/de active Pending
-
1977
- 1977-04-28 ES ES458264A patent/ES458264A1/es not_active Expired
- 1977-04-29 NL NL7704739A patent/NL7704739A/xx not_active Application Discontinuation
- 1977-05-02 IT IT23096/77A patent/IT1086223B/it active
- 1977-05-03 GB GB18427/77A patent/GB1583163A/en not_active Expired
- 1977-05-03 DK DK194377A patent/DK194377A/da unknown
- 1977-05-04 JP JP5194577A patent/JPS52133975A/ja active Pending
- 1977-05-04 BE BE177278A patent/BE854268A/fr unknown
- 1977-05-04 FR FR7713518A patent/FR2372806A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES458264A1 (es) | 1978-07-16 |
| IT1086223B (it) | 1985-05-28 |
| DE2619638A1 (de) | 1977-11-17 |
| DK194377A (da) | 1977-11-05 |
| BE854268A (fr) | 1977-11-04 |
| NL7704739A (nl) | 1977-11-08 |
| FR2372806A1 (fr) | 1978-06-30 |
| GB1583163A (en) | 1981-01-21 |
| JPS52133975A (en) | 1977-11-09 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |